Kanchanar: Benefits, Evidence & Safety
TL;DR
Kanchanar (Bauhinia variegata) bark is Ayurveda's classical herb for gandamala, glandular swellings and goiter-like conditions, usually taken as the polyherbal Kanchanara Guggulu. Human evidence is thin: one small 60-day RCT (n=46) used Kanchanara Guggulu as a comparator arm for hypothyroidism, and rat studies show goiter-model effects. It is not a proven thyroid treatment.
(55 words. Sources: Vivek et al. 2025, RCT; Gautam, IJAPR critical review; Veena et al., in-vivo antigotrogenic study.)
What it is
Kanchanar (also spelled Kanchnar or Kachnar) is the stem bark, and sometimes the flower, of Bauhinia variegata Linn., a medium-sized deciduous tree of the pea family (Fabaceae), called "Mountain Ebony" in English (Gautam, IJAPR critical review). It grows in the sub-Himalayan tract from the Indus eastwards and across the forests of India and Myanmar. Phytochemical reviews record terpenoids, flavonoids, tannins, saponins, steroids and cardiac glycosides in the plant (Ayushdhara review). A taxonomic caution: other Bauhinia species (notably B. purpurea, called Kovidar) are sometimes used interchangeably as Kanchanara in Ayurvedic practice (Gautam, IJAPR).
Traditional use
Kanchanar's signature classical epithet is Gandamalanashaka: "dispeller of gandamala," the Ayurvedic category covering cervical lymph-node swellings, scrofulous glands and goiter-like neck swellings (Gautam, IJAPR). Charaka and Sushruta mentioned its relatives Kovidara and Karbudara in the Samhitas, and Chakradatta specifically recommends Kanchnar for gandamala (same review). The classical action list also includes grahi (absorbent), krimighna (anthelmintic), kushtaghna (skin-disease remedy) and vranaropaka (wound-healing) (same review).
In practice kanchanar is rarely used alone. It is the namesake ingredient of Kanchanara Guggulu, a polyherbal tablet that also contains guggul resin, triphala and trikatu, and of formulations such as Kanchanara gutika and Kanchanaradi Kwatha (same review). These are traditional uses, not clinical proof: the human evidence is assessed separately below.
What modern research says
Hypothyroidism
There is exactly one relevant randomized trial, and it was not designed to prove Kanchanara Guggulu works. In a 2025 randomized controlled trial (n=46, 60 days) of primary hypothyroidism with suboptimal response to stable levothyroxine therapy, one arm received Kanchanara Guggulu (two 500 mg tablets, thrice daily with water) while the other received a "whole system Ayurveda protocol" (Vivek et al., J-AIM via PMC). Both groups improved from baseline on BMI, waist-hip ratio, quality-of-life and clinical scores, but the whole-system arm outperformed the Kanchanara Guggulu arm on several outcomes (same trial).
What this shows: Kanchanara Guggulu was the control intervention in an add-on trial: there was no placebo arm, no levothyroxine-free comparison, and the tested product was a polyherbal formulation (not kanchanar bark alone). It cannot establish that kanchanar treats hypothyroidism.
Goiter and thyroid models (animals only)
In rats with neomercazole-induced goiter, B. variegata reportedly restored goitrogenic thyroids toward normal at 200 mg/day (Veena et al., cited in the Himalayan Journal of Health Sciences review). A separate rat study tested ethanolic extracts of B. variegata combined with Commiphora mukul gum resin for hypothyroidism and called the combination a potential strategy (Journal of Pharmacognosy and Phytochemistry). Both are animal studies of extracts: not human evidence.
What the evidence does not support (yet)
No placebo-controlled human trial has tested kanchanar (or Kanchanara Guggulu) for thyroid disease, goiter reduction, or any other condition. The broader pharmacological activities catalogued in reviews, anti-inflammatory, antioxidant, immunomodulatory, antidiabetic, nephroprotective, come overwhelmingly from animal and laboratory studies (Ayushdhara review; Gautam, IJAPR).
Dosage
No clinical dose of kanchanar bark alone has been tested in humans. The only trial regimen on record is for the polyherbal formulation: Kanchanara Guggulu, two 500 mg tablets thrice daily (3 g/day) with water for 60 days: the comparator arm of the Vivek et al. hypothyroidism RCT (trial). That is a research regimen for a specific formulation, not a personal recommendation and not a dose for plain kanchanar bark powder.
Safety & contraindications
Human safety data for kanchanar are sparse. The key caution is clinical, not toxicological: hypothyroidism is managed with levothyroxine, and the only RCT tested Kanchanara Guggulu as an add-on to stable thyroid-hormone therapy: never as a replacement (trial). Stopping or substituting thyroid medication without medical supervision risks serious harm, and any neck swelling or goiter needs medical evaluation first (a "gandamala" can have causes far beyond what any herb addresses).
Avoid use in pregnancy and breastfeeding: there are no safety data for these groups. Because thyroid conditions overlap with autoimmune disease and cardiac risk, anyone with a thyroid diagnosis, heart condition, or on hormone or cardiac medication should use kanchanar only with their doctor's knowledge. No established interactions are documented, which reflects the thin evidence base rather than proven safety.
FAQs
What is kanchanar used for in Ayurveda?
Kanchanar (Bauhinia variegata bark) is Ayurveda's classical herb for gandamala, glandular swellings of the neck, scrofulous glands and goiter-like conditions, reflected in its epithet Gandamalanashaka (Gautam, IJAPR). It is most often taken as the polyherbal formulation Kanchanara Guggulu (same review).
Is kanchanar proven to treat thyroid problems?
No. The single relevant human trial (n=46, 60 days) used Kanchanara Guggulu as the control arm in an add-on study of hypothyroidism on stable levothyroxine: not a placebo comparison, and it tested a polyherbal tablet, not kanchanar alone (Vivek et al.). Rat studies show goiter-model effects, but these are not human evidence (hjhs review).
What is Kanchanara Guggulu?
A classical polyherbal tablet named for kanchanar bark, combined with guggul (Commiphora mukul) resin, triphala, trikatu and other herbs: one of the formulations most used by Ayurvedic physicians for thyroid and glandular conditions (Gautam, IJAPR).
Can kanchanar replace thyroid medication?
No. The only RCT studied it as an add-on to stable levothyroxine therapy, not as a substitute (Vivek et al.). Never stop or replace thyroid hormone medication without your doctor.
Is kanchanar safe?
Human safety data are limited. It should be avoided in pregnancy and breastfeeding for lack of data, and anyone with thyroid disease, heart disease, or on prescription medication should involve their doctor. A thin evidence base cannot establish safety: do not treat limited reporting as proof of no risk.
Sources
- Vivek et al. "Add on effect of Whole System Ayurveda protocol in suboptimal controlled Primary Hypothyroidism — A randomized controlled trial." Journal of Ayurveda and Integrative Medicine. 2025 (PMCID: PMC11773014) — PMC · PMC11773014
- Gautam R. "Kanchnara (Bauhinia variegata Linn.): A Critical Review." International Journal of Ayurveda and Pharma Research — ijapr.in
- Thakur T et al. "A review on Bauhinia variegata and its phytoconstituents." Ayushdhara — ayushdhara.in
- Gitika et al. "Bauhinia variegata" (antigotrogenic rat study of Veena et al.). Himalayan Journal of Health Sciences — hjhs.co.in
- "Anti-hypothyroid potential of Bauhinia variegata" (rat study, combination with Commiphora mukul). Journal of Pharmacognosy and Phytochemistry — phytojournal.com
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.